115 related articles for article (PubMed ID: 38478175)
1. Comparative Bioequivalence and Food Effect of Two Formulations of 30-mg Nifedipine Controlled-Release Tablets in Healthy Chinese Adults.
Zhang H; Wang S; Wang H; Zhi T; Ren J; Wang Y; Yao Z; Zhang P; Ye N; Zhang R
Clin Pharmacol Drug Dev; 2024 May; 13(5):499-505. PubMed ID: 38478175
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and Bioequivalence of 2 Nifedipine Controlled-Release Tablets: A Randomized, Single-Dose, 2-Period Crossover Study in Healthy Chinese Volunteers Under Fasting and Fed Conditions.
Xin L; Chen Q; Chen D; Li Y; Li Y; Wu Q; Zou Y; Wang W; Jia J; Yu C; Liu Y
Clin Pharmacol Drug Dev; 2023 Nov; 12(11):1082-1088. PubMed ID: 37132398
[TBL] [Abstract][Full Text] [Related]
3. Differences in bioavailability between 60 mg of nifedipine osmotic push-pull systems after fasted and fed administration.
Anschütz M; Wonnemann M; Schug B; Toal C; Donath F; Pontius A; Pauli K; Brendel E; Blume H
Int J Clin Pharmacol Ther; 2010 Feb; 48(2):158-70. PubMed ID: 20137768
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and bioequivalence evaluation of two formulations of 10-mg amlodipine besylate: an open-label, single-dose, randomized, two-way crossover study in healthy Chinese male volunteers.
Liu Y; Jia J; Liu G; Li S; Lu C; Liu Y; Yu C
Clin Ther; 2009 Apr; 31(4):777-83. PubMed ID: 19446150
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and Bioequivalence of 2 Immediate-Release Tofacitinib Tablet Formulations in Chinese Healthy Volunteers Under Fasting and Fed Conditions.
Li X; Liu L; Deng Y; Li Y; Zhang P; Wang Y; Xu B; Feng J; Huang L
Clin Pharmacol Drug Dev; 2021 May; 10(5):535-541. PubMed ID: 32770665
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and bioequivalence of Ezetimibe tablet versus Ezetrol®:an open-label, randomized, two-sequence crossover study in healthy Chinese subjects.
Sun F; Liu Y; Li T; Lin P; Jiang X; Li X; Wang C; Gao X; Ma Y; Fu Y; Cao Y
BMC Pharmacol Toxicol; 2023 Feb; 24(1):7. PubMed ID: 36737825
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and Bioequivalence of Apremilast Tablets in Chinese Healthy Subjects Under Fasting and Postprandial States.
Bai W; Sun X; Qiu B; Guo C; Song H; Hu Y; Zhang X; Yin P; Wang X; Dong Z
Drug Des Devel Ther; 2024; 18():2273-2285. PubMed ID: 38895175
[TBL] [Abstract][Full Text] [Related]
8. Bioequivalence of two quetiapine extended release tablets in Chinese healthy volunteers under fasting and fed conditions and effects of food on pharmacokinetic profiles.
Huang X; Zhang S; Ma Y; Yang H; He C; Tian R; Mei H; Liu L; Zhang B
Drug Des Devel Ther; 2019; 13():255-264. PubMed ID: 30643391
[TBL] [Abstract][Full Text] [Related]
9. A crossover study to evaluate the pharmacokinetics and bioequivalence of hydroxychloroquine tablets in healthy Chinese subjects.
Feng J; Kuang SY; Wan JH; Li R; Zhu YJ; Cai BL; Guan L; Zhang Z
Int J Clin Pharmacol Ther; 2024 Jun; 62(6):284-292. PubMed ID: 38577751
[TBL] [Abstract][Full Text] [Related]
10. Bioequivalence Study of Vortioxetine Hydrobromide Tablets in Healthy Chinese Subjects Under Fasting and Fed Conditions.
Bai W; Song H; Hu Y; Zhang X; Wang X; Guo C; Qiu B; Dong Z
Drug Des Devel Ther; 2023; 17():3035-3046. PubMed ID: 37795495
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic and Tolerability Comparison of Sustained and Immediate Release Oral Formulations of Nifedipine Tablet Formulations: A Single-Dose, Randomized, Open-Label, Two-Period, Two-Way Crossover Study in Healthy, Fasting Egyptian Male Volunteers.
El-Masry SM; El-Khodary NM
Drug Res (Stuttg); 2020 Feb; 70(2-03):91-96. PubMed ID: 31746448
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of Nifedipine-Sustained Release Tablets in Healthy Subjects After a Single Oral Administration: Bioequivalence Analysis and Food Effects.
Wu YX; Zhong XF; Li XM; Liu WL; Zhang YX; Shen QY; Xu SM; Xu PS
Clin Pharmacol Drug Dev; 2023 Nov; 12(11):1076-1081. PubMed ID: 37243536
[TBL] [Abstract][Full Text] [Related]
14. Bioequivalence study of two perindopril tert-butylamine tablet formulations in healthy Chinese subjects under fasting and fed conditions: A randomized, open-label, single-dose, crossover trial.
Li Q; Hao Z; Yu Y; Tang Y
Biomed Pharmacother; 2021 Mar; 135():111221. PubMed ID: 33433351
[TBL] [Abstract][Full Text] [Related]
15. Comparative Pharmacokinetics and Bioequivalence Evaluation of Two Formulations of Pramipexole Dihydrochloride Extended-Release Tablets in Healthy Chinese Subjects Under Fasted and Fed States: A Randomized, Open-Label, Single-Dose, Two-Period Crossover Clinical Trial.
Yang L; Zhang L; Luo Z
Drug Des Devel Ther; 2023; 17():2369-2381. PubMed ID: 37600497
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and Bioequivalence Evaluation of Two Montelukast Sodium Chewable Tablets in Healthy Chinese Volunteers Under Fasted and Fed Conditions.
Li W; Wang Y; Pei Y; Xia Y
Drug Des Devel Ther; 2021; 15():1091-1099. PubMed ID: 33727797
[TBL] [Abstract][Full Text] [Related]
17. Comparison of scaled-average, population, and individual bioequivalence on 2 tablets of pitavastatin calcium: a 3-period, reference-replicated, crossover study in healthy Chinese volunteers.
Huang YH; Li ZQ; Pan GX; Li YF; Liu Y; Sun JX; Gu XF; Li N; Wang BH
Clin Ther; 2014 Sep; 36(9):1205-1216.e6. PubMed ID: 25234550
[TBL] [Abstract][Full Text] [Related]
18. Bioequivalence and Pharmacokinetic Evaluation of Two Metformin Hydrochloride Tablets Under Fasting and Fed Conditions in Healthy Chinese Volunteers.
Huang XM; Wang GZ; He BB; Gao T; Long P; Zhang BK
Clin Pharmacol Drug Dev; 2020 Nov; 9(8):910-917. PubMed ID: 32936533
[TBL] [Abstract][Full Text] [Related]
19. Significant food interactions observed with a nifedipine modified-release formulation marketed in the European Union.
Wonnemann M; Schug B; Schmücker K; Brendel E; van Zwieten PA; Blume H
Int J Clin Pharmacol Ther; 2006 Jan; 44(1):38-48. PubMed ID: 16425970
[TBL] [Abstract][Full Text] [Related]
20. Bioequivalence of a Generic Nateglinide Formulation in Healthy Chinese Volunteers under Fasting and Fed Conditions: A Randomized, Open-Label, Double-Cycle, Double-Crossover Study.
Yu M; Li X; Jin H; Chen L; Wang N; Wang H; Cao Y; Sui X; Gao X; Yang H; Wang W
Pharmacology; 2021; 106(7-8):418-425. PubMed ID: 33866315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]